
    
      This is a randomized, multicenter, double-blind, vehicle-controlled, 2 arm study to evaluate
      the safety and efficacy over 12 weeks of FMX101 topical foam containing 4% minocycline
      compared to vehicle in the treatment of subjects with moderate-to-severe facial acne
      vulgaris. Qualified subjects will be randomized to receive 1 of the following 2 treatments:

        -  FMX101 4% minocycline foam

        -  Vehicle foam
    
  